ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individuals condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLEs Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The companys cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patients cancer for personalized cancer care. The companys harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ANGLE Acquires Assets from Axela 11
Private Equity 12
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Partnerships 13
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Equity Offering 15
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc - Key Competitors 19
ANGLE Plc - Key Employees 20
ANGLE Plc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2018: ANGLE: Preliminary Results for the year ended 30 April 2018 22
Corporate Communications 26
Nov 01, 2018: Appointment of Dr Jan Groen as non-executive director 26
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List Of Tables


ANGLE Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Acquires Assets from Axela 11
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc, Key Competitors 19
ANGLE Plc, Key Employees 20
ANGLE Plc, Other Locations 21

List Of Figures


ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9

Angle Biosciences Inc - Medical Equipment - Deals and Alliances Profile

Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors,

USD 250 View Report

ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

USD 250 View Report

ANGLE Plc (AGL) - Medical Equipment - Deals and Alliances Profile

ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate

USD 250 View Report

ANGLE PLC Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

ANGLE PLC Company Profile is a detailed strategic and analytical report on ANGLE PLC. The 2018 version of the report offers detailed insights into the companys strategies, developments, outlook and

USD 200 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available